Literature DB >> 7042609

Demonstration of mycobacterial antigens in leprosy tissues.

R N Mshana, A Belehu, G L Stoner, M Harboe, A Haregewoin.   

Abstract

Biopsies from 69 patients with leprosy were stained to demonstrate mycobacterial antigens using immunoperoxidase methods. The same biopsies were cut and stained using Fite-Faraco, TRIFF and hematoxylin-eosin for classifying the patients and to demonstrate mycobacteria. Since M. leprae and BCG show extensive antigenic cross reactions, anti-BCG antibodies were used as primary antisera to demonstrate cross-reacting antigens of M. leprae. Cross-reacting mycobacterial antigens were, thus, found in all LL and BL leprosy patients. Eight out of 10 patients with indeterminate leprosy had mycobacterial antigens and 17 out of 19 BT leprosy patients were positive for antigens. In general, in the BT patients the presence of the antigen was related to the host tissue reaction; this relationship was found in only half of the patients with indeterminate leprosy studied. During ENL mycobacterial antigens were found both intra- and extra-cellularly in the inflammatory infiltrate, but the polymorphonuclear leukocyte infiltration was seen only around the extracellular perivascular antigen. In reversal reaction, the inflammatory response was towards extracellular mycobacterial antigens. After this reaction there were no antigens demonstrable.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042609

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  9 in total

1.  Demonstration of Mycobacterium leprae antigen in nerves of tuberculoid leprosy.

Authors:  U Barros; V P Shetty; N H Antia
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.

Authors:  C Verhagen; W Faber; P Klatser; A Buffing; B Naafs; P Das
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

3.  A morphological study of nerve biopsies from cases of multibacillary leprosy given multidrug therapy.

Authors:  J M Jacobs; V P Shetty; N H Antia
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues.

Authors:  A Rambukkana; J D Burggraaf; W R Faber; M Harboe; P Teeling; S Krieg; P K Das
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Immunohistochemical staining of macrophages in the skin lesions of leprosy: the role of antibody to mycobacteria in human serum and various polyclonal immune rabbit antisera.

Authors:  H J Kahn; P Thorner; R Baumal; H Yeger; D Bailey; A Marks; L From; B K Fisher; C Lynde
Journal:  Histochem J       Date:  1985-09

6.  Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy.

Authors:  V P Shetty; M W Uplekar; N H Antia
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Immunohistological studies of skin biopsies from patients with lepromatous leprosy.

Authors:  R N Mshana; D P Humber; A Belehu; M Harboe
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

8.  Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria.

Authors:  R N Mshana; D P Humber; M Harboe; A Belehu
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

9.  Leprosy: a review of laboratory and therapeutic aspects--part 2.

Authors:  Joel Carlos Lastória; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.